Evidence map›Paper›PMID 37685924›Full record

ArticleInternational journal of molecular sciences2023

A Scoping Review on Biomarkers of Endothelial Dysfunction in Small Vessel Disease: Molecular Insights from Human Studies.

Daniela Jaime Garcia, Audrey Chagnot, Joanna M Wardlaw, Axel Montagne

Open access · goldAbstract readScoping Review
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Plasma proteomics of cerebrovascular disease, cognitive decline, and clinical outcomes.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Review
  6. Review
  7. The role of inflammation in cerebral small vessel disease and vascular cognitive impairment, and therapeutic implications.International journal of stroke : official journal of the International Stroke Society · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The Emerging Role of the DDAH Proteins in Psychiatric Disorders.Biological psychiatry global open science · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Daniela Jaime GarciaCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK.ORCID 0000-0002-9457-9855
Audrey ChagnotUK Dementia Research Institute, University of Edinburgh, Edinburgh EH16 4SB, UK.
Joanna M WardlawCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK.ORCID 0000-0002-9812-6642
Axel MontagneCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK.ORCID 0000-0001-5564-985X
UK Dementia Research Institute · GB

Funding

Medical Research Council MR/V032488/1Wellcome Trust
6 · The paper itself

Abstract

Small vessel disease (SVD) is a highly prevalent disorder of the brain's microvessels and a common cause of dementia as well as ischaemic and haemorrhagic strokes. Though much about the underlying pathophysiology of SVD remains poorly understood, a wealth of recently published evidence strongly suggests a key role of microvessel endothelial dysfunction and a compromised blood-brain barrier (BBB) in the development and progression of the disease. Understanding the causes and downstream consequences associated with endothelial dysfunction in this pathological context could aid in the development of effective diagnostic and prognostic tools and provide promising avenues for potential therapeutic interventions. In this scoping review, we aim to summarise the findings from clinical studies examining the role of the molecular mechanisms underlying endothelial dysfunction in SVD, focussing on biochemical markers of endothelial dysfunction detectable in biofluids, including cell adhesion molecules, BBB transporters, cytokines/chemokines, inflammatory markers, coagulation factors, growth factors, and markers involved in the nitric oxide cascade.

Indexed as

Vascular DiseasesBiomarkersBlood-Brain BarrierCytokinesHumansMicrovesselsBiomarkersCytokinesblood–brain barriercerebrovascular dysfunctionendothelial activationendothelial cellsendothelial dysfunctionlacunar strokelacunemicrobleedsperivascular spacessmall vessel diseasevascular dementiawhite matter hyperintensities

Identifiers

PMID37685924
PMCPMC10488088
OpenAlexW4386098809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.